Scientists have discovered that an active ingredient in an over-the-counter skin cream slows or stops the effects of Parkinson’s disease on brain cells.
The active ingredient in an over-the-counter skin cream might do more than prevent wrinkles. Scientists have discovered that the drug, called kinetin, also slows or stops the effects of Parkinson’s disease on brain cells.
Scientists identified the link through biochemical and cellular studies, but the research team is now testing the drug in animal models of Parkinson’s. The research is published in the August 15, 2013 issue of the journal Cell.
“Kinetin is a great molecule to pursue because it’s already sold in drugstores as a topical anti-wrinkle cream,” says HHMI investigator Kevan Shokat of the University of California, San Francisco. “So it’s a drug we know has been in people and is safe.”
Parkinson’s disease is a degenerative disease that causes the death of neurons in the brain. Initially, the disease affects one’s movement and causes tremors, difficulty walking, and slurred speech. Later stages of the disease can cause dementia and broader health problems. In 2004, researchers studying an Italian family with a high prevalence of early-onset Parkinson’s disease discovered mutations in a protein called PINK1 associated with the inherited form of the disease.
Since then, studies have shown that PINK1 normally wedges into the membrane of damaged mitochondria inside cells that causes another protein, Parkin, to be recruited to the mitochondria, which are organelles responsible for energy generation. Neurons require high levels of energy production, therefore when mitochondrial damage occurs, it can lead to neuronal death. However, when Parkin is present on damaged mitochondria, studding the mitochondrial surface, the cell is able to survive the damage. In people who inherit mutations in PINK1, however, Parkin is never recruited to the organelles, leading to more frequent neuronal death than usual.
Shokat and his colleagues wanted to develop a way to turn on or crank up PINK1 activity, therefore preventing an excess of cell death, in those with inherited Parkinson’s disease. But turning on activity of a mutant enzyme is typically more difficult than blocking activity of an overactive version.
“When we started this project, we really thought that there would be no conceivable way to make something that directly turns on the enzyme,” says Shokat. “For any enzyme we know that causes a disease, we have ways to make inhibitors but no real ways to turn up activity.”
His team expected it would have to find a less direct way to mimic the activity of PINK1 and recruit Parkin. In the hopes of more fully understanding how PINK1 works, they began investigating how PINK1 binds to ATP, the energy molecule that normally turns it on. In one test, instead of adding ATP to the enzymes, they added different ATP analogues, versions of ATP with altered chemical groups that slightly change its shape. Scientists typically must engineer new versions of proteins to be able to accept these analogs, since they don’t fit into the typical ATP binding site. But to Shokat’s surprise, one of the analogs—kinetin triphosphate, or KTP—turned on the activity of not only normal PINK1, but also the mutated version, which doesn’t bind ATP.
“This drug does something that chemically we just never thought was possible,” says Shokat. “But it goes to show that if you find the right key for the right lock, you’ll be able to open the door.”
To test whether the binding of KTP to PINK1 led to the same consequences as the usual ATP binding, Shokat’s group measured the activity of PINK1 directly, as well as the downstream consequences of this activity, including the amount of Parkin recruited to the mitochondrial surface, and the levels of cell death. Adding the precursor of KTP, kinetin, to cells—both those with PINK1 mutations and those with normal physiology—amplified the activity of PINK1, increased the level of Parkin on damaged mitochondria, and decreased levels of neuron death, they found.
“What we have here is a case where the molecular target has been shown to be important to Parkinson’s in human genetic studies,” says Shokat. “And now we have a drug that specifically acts on this target and reverses the cellular causes of the disease.”
The Latest Bing News on:
- Running for Rick: Cross-country team plans race to honor coach dealing with Parkinson's diseaseon March 28, 2023 at 10:19 pm
After watching their cross-country coach deal with the effects of Parkinson’s disease since his diagnosis two years ago, Decatur High students Sam Hellebrand and Wyatt Jones hit the ground running ...
- Scientists shed new light on two proteins that exacerbate the progression of Parkinson's diseaseon March 28, 2023 at 9:29 am
Two proteins may be intimately linked to the progression of Parkinson's disease, a relentless and disabling neurodegenerative disorder that affects millions of people around the world.
- Parkinson's Foundation Launches #Take6forPD Campaign for Parkinson's Awareness Monthon March 28, 2023 at 7:55 am
Experience the full interactive Multichannel News Release here: "Nearly one million people in the U.S. are living with Parkinson's disease, and by 2030, the number is expected to reach 1.2 million," ...
- These Biotechs Aim to Treat Parkinson's Disease Via Inflammation And Other Novel Approacheson March 28, 2023 at 7:01 am
A key challenge with investing in biotech stocks is figuring out which disease areas might offer the best promise. However, one area of biotech that's ripe for investment is treatments for ...
- What Is Parkinson’s Disease?on March 28, 2023 at 6:18 am
Parkinson's disease is a neurological disorder characterized by tremors and affects muscle and motor function. Learn about the early signs and symptoms of Parkinson's and the causes, diagnosis, and ...
- Exclusive: Michael J. Fox Foundation Announces Winner Of Parkinson’s Disease Research Prize Funded By Billionaire Ken Griffinon March 28, 2023 at 3:31 am
A $10 million Parkinson’s disease research competition launched in 2019 spurred progress toward measuring a protein linked to the disease. The hope is that it could help with earlier diagnosis and ...
- Parkinson's Disease is a Serious Brain Disorder: Is There Any Cure? All FAQ'S Answered by Experton March 27, 2023 at 10:43 pm
The cause of Parkinson's disease is unknown, but several factors appear to play a role. Here are some frequently asked questions answered by expert about this serious brain disorder.
- A Neurologist Debunks The Top 3 Myths About Parkinson's Diseaseon March 27, 2023 at 10:11 am
Parkinson's disease is a neurodegenerative condition surrounded by myths. Health Digest spoke with an expert who dispels some of the most common.
- Removing ovaries before age 43 may raise risk of Parkinson's diseaseon March 27, 2023 at 7:01 am
Women who have both of their ovaries removed before age 43 have an increased risk of developing Parkinson's disease or parkinsonism, according to a recent study.
- Parkinson's Research Newson March 26, 2023 at 5:00 pm
Jan. 10, 2023 — New research says the gut microbiome is involved in multiple pathways in the pathogenesis of Parkinson's disease. The findings show a wide imbalance in microbiome composition in ...
The Latest Google Headlines on:
[google_news title=”” keyword=”Parkinson’s Disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
- Influence of Kinetin, β-lndoleacetic Acid and Gibberellic Acid on Nuclease Activity of Bean (Phaseolis vulgaris) Hypocotylson February 2, 2023 at 12:27 am
Skoog, F., and Miller, C. O., Symp. Soc. Exp. Biol., No. 11, 118 (1957). Silberger, J., and Skoog, F., Science, 118, 443 (1953).
- Interaction between Kinetin and Indoleacetic Acid in the Control of Bud Reactivation in Splachnum ampullaceum (L.) Hedw.on September 10, 2022 at 10:03 pm
IT has been shown 1 that the apical region of the gametophore of Splachnum ampulloceum (L.) Hedw. inhibits both lateral bud reactivation throughout the gametophore and protonematal regeneration ...
- Vitamins & Supplements Centeron August 16, 2020 at 1:05 pm
Considering taking a vitamin or supplement to treat Aging+Skin? Below is a list of common natural remedies used to treat or reduce the symptoms of Aging+Skin. Follow the links to read common uses ...
- Pollinating Sprays for Vegetable Gardenson May 27, 2015 at 6:35 am
These sprays contain kinetin, a variety of the cytokinin hormone. Kinetin is a synthetic compound that fosters cytokinesis or cell division. Pollinating sprays cause fruit to develop even when the ...
- Vitamins & Supplements Centeron February 20, 2015 at 5:20 pm
Considering taking a vitamin or supplement to treat Wrinkled+Skin? Below is a list of common natural remedies used to treat or reduce the symptoms of Wrinkled+Skin. Follow the links to read common ...
The Latest Google Headlines on:
[google_news title=”” keyword=”kinetin” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]